Trial Information

Pancreatic Cancer Serum and Peripheral Blood Lymphocyte Repository

OBJECTIVES:

- Establish a central pancreatic cancer specimen (including serum and peripheral blood
lymphocytes) repository to serve as a resource for current or future scientific
studies.

- Utilize the clinical database to perform clinicopathologic correlation with the results
of those studies.

- Test new hypotheses as they emerge.

OUTLINE: This is a prospective study.

Blood is collected from patients with pancreatic cancer at baseline and then every 3-6
months for up to 2 years. All other participants have blood collected at baseline and
complete questionnaires at baseline and then every 3-6 months for up to 2 years. Serum and
peripheral blood lymphocytes obtained from the blood samples are frozen and stored.

PROJECTED ACCRUAL: A total of 200 patients and 200 other participants will be accrued for
this study.